SCHEMBL7311618

SCHEMBL7311618

CCCCC(NC(=O)C(CC(C)C)NC(=O)C=Cc1ccc(OC)cc1)C(=O)CSCc1ccco1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TAS1R3 Q7RTX0 7/20 0.53
TAS1R1 Q7RTX1 7/20 0.53
ALDH1A1 P00352 4/20 0.53
MAPT P10636 3/20 0.53
HPGD P15428 2/20 0.53
KDM4E B2RXH2 2/20 0.41
GAA P10253 1/20 0.40
RECQL P46063 1/20 0.40
NOS3 P29474 3/20 0.40
NOS1 P29475 3/20 0.40
NOS2 P35228 3/20 0.40
SMN1; SMN2 Q16637 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
PTGS1 P23219 1/20 0.38
PTGS2 P35354 1/20 0.38
LMNA P02545 1/20 0.38
TP53 P04637 1/20 0.38
HTT P42858 1/20 0.38
TDP1 Q9NUW8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7311611 1.00 TAS1R3 (0.53) TAS1R3TAS1R1ALDH1A1MAPTHPGD
SCHEMBL7311608 1.00 TAS1R3 (0.53) TAS1R3TAS1R1ALDH1A1MAPTHPGD
SCHEMBL7311615 0.88 ALDH1A1 (0.53) TAS1R3TAS1R1ALDH1A1MAPTHPGD
SCHEMBL7300813 0.87 CTSS (0.44) TAS1R3TAS1R1ALDH1A1MAPTHPGD
SCHEMBL7300831 0.87 CTSS (0.44) TAS1R3TAS1R1ALDH1A1MAPTHPGD
SCHEMBL7306949 0.85 HPGD (0.42) ALDH1A1MAPTHPGDRECQLSMN1; SMN2
SCHEMBL7431367 0.85 HPGD (0.42) ALDH1A1MAPTHPGDRECQLSMN1; SMN2
SCHEMBL7306399 0.83 POLB (0.50) TAS1R3TAS1R1ALDH1A1MAPTHPGD
SCHEMBL7306413 0.83 POLB (0.50) TAS1R3TAS1R1ALDH1A1MAPTHPGD
SCHEMBL7438981 0.81 POLB (0.40) ALDH1A1MAPTHPGDRECQLSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0525420-B1 Pseudopeptides and dipeptides characterised by a substituted methyl ketone moiety at the C-terminus as thiol protease inhibitors MITSUBISHI CHEM CORP (JP) 1999-05-12 EP disclosed
US-5639783-A POTENT PROTEASE INHIBITOR FOR TREATING MUSCULAR, NERVOUS SYSTEM DISEASES MITSUBISHI CHEMICAL CORPORATION (JP) 1997-06-17 US disclosed
EP-0525420-A1 Pseudopeptides and dipeptides characterised by a substituted methyl ketone moiety at the C-terminus as thiol protease inhibitors Mitsubishi Chemical Corporation (JP) 1993-02-03 EP disclosed